Basic Information
| LncRNA/CircRNA Name | MAGI2-AS3 |
| Synonyms | NA |
| Region | GRCh38_7:79452877-79471208 |
| Ensemble | ENSG00000234456 |
| Refseq | NR_038343 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qRT-PCR etc. |
| Sample | human glioma tissues and the matched tumor-adjacent tissues , |
| Expression Pattern | down-regulated |
| Function Description | The relative expression level of MAGI2-AS3 in glioma tissues was significantly lower than those in adjacent normal brain tissues.Patients with low MAGI2-AS3 expression levels tended to have worse overall survival than those with high levels of MAGI2-AS3 expression.MAGI2-AS3 expression in glioma tissues was an independent prognostic factor for overall survival. |
| Pubmed ID | 31081100 |
| Year | 2019 |
| Title | Expression of Long Non-Coding RNA MAGI2-AS3 in Human Gliomas and Its Prognostic Significance |
External Links
| Links for MAGI2-AS3 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |